Androgen deprivation drives prostate cancer cells into a glycolysis-coupled senescence-like state
The cellular origin, clinical significance, and metabolic features of the senescence-associated secretory phenotype (SASP) in prostate cancer remain poorly resolved. We integrated bulk transcriptomes from TCGA-PRAD (primary, n = 495) and SU2C (mCRPC, n = 208), two single-cell RNA-sequencing datasets, seven Visium sections, and one Xenium prostate adenocarcinoma section, together with immunoblotting in LNCaP and castration-adapted C4-2 cells treated with charcoal-stripped serum (CSS), enzalutamide (ENZ), and dihydrotestosterone (DHT). SASP formed a smooth, continuous gradient across bulk tumors rather than discrete subtypes. In Xenium, 4,657 of 25,517 tumor cells (18.3%) were positive for a senescence surrogate driven predominantly by p21 (CDKN1A) transcript detection; the local fraction of these cells correlated with a bin-level matrix-remodeling SASP program and glycolysis, but not with inflammatory SASP. The single-cell atlas revealed expansion of AR-low, stasis/senescence-like states in advanced disease. Within the adenocarcinoma compartment of one CRPC section, senescence-like hotspots showed higher glycolysis scores without a concomitant rise in proliferation. In vitro, CSS and ENZ increased p21/p16 and glycolytic proteins (GLUT1, LDHA, HK2), and treatment with 2-deoxy-D-glucose (2-DG) or the LDHA inhibitor FX-11 was associated with lower p21/p16 abundance. Androgen deprivation is associated with a prostate cancer senescence-like state and a glycolysis-related program; LDHA is a candidate metabolic node for further investigation; the present data do not establish therapeutic selectivity or efficacy. These spatial associations do not establish the cellular source of the SASP-related transcripts or paracrine signaling.
Authors
- Can Wei (ORCID: https://orcid.org/0000-0003-4291-7653)
- Jianye Yang
- Jing Xu
- Rongrong Li
- Gege Yuan
- Yanbin Zhang
Institutions
- Shanghai Medical College of Fudan University (CN)
- Anhui Medical University (CN)
- Fudan University (CN)
- Nanjing Children's Hospital (CN)
- Fudan University Shanghai Cancer Center (CN)
- First Affiliated Hospital of Anhui Medical University (CN)
- Second Affiliated Hospital of Nanjing Medical University (CN)
- Second Affiliated Hospital of Anhui Medical University (CN)
- Third People's Hospital of Hefei (CN)
- Nanjing Medical University (CN)
Publication Details
- Journal
- Translational Oncology
- Published
- 2026-11-18
- DOI
- https://doi.org/10.1016/j.tranon.2026.103120
- Primary Topic
- Prostate Cancer Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China